Computationally optimized broadly reactive antigens for influenza
AssigneeUniversity of Pittsburgh—Of the Commonwealth System of Higher Education
InventorsTed M. Ross, Brendan M. Giles
Life of this patent
Estimating the term…
Abstract
The development of a computationally optimized influenza HA protein that elicits broadly reactive immune response to all H5N1 influenza virus isolates is described. The optimized HA protein was developed through a series of HA protein alignments, and subsequent generation of consensus sequences, for clade 2 H5N1 influenza virus isolates. The final consensus HA amino acid sequence was reverse translated and optimized for expression in mammalian cells. Influenza virus-like particles containing the optimized HA protein are an effective vaccine against H5N1 influenza virus infection in animals.
Claims7
A method of eliciting a broadly reactive immune response against influenza virus in a subject, comprising
- generating an optimized influenza virus polypeptide sequence comprising the steps of:
- (i) obtaining the amino acid sequences of the polypeptide from a group of influenza virus isolates, wherein the influenza virus isolates are from the same subtype;
- (ii) organizing the amino acid sequences of the polypeptide from the group of influenza virus isolates by clade or sub-clade and then by geographical region within each clade or sub-clade;
- (iii) aligning the amino acid sequences within each geographical region to generate primary consensus sequences, wherein each geographic region is represented by a primary consensus sequence;
- (iv) aligning the primary consensus sequences to generate secondary consensus sequences, wherein each clade or sub-clade is represented by a secondary consensus sequence;
- and
- (v) aligning the secondary consensus sequences, thereby generating the optimized influenza virus polypeptide sequence;
- and
- administering the optimized influenza virus polypeptide to the subject.
Dependencies are inferred from the claim text.